Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Surgery|December 3, 2014
Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancerCameron D Adkisson, Gina M Howell, Kelly L McCoy, et al.
Surgery|December 5, 2009
Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutationLinwah Yip, Marina N Nikiforova, Sally E Carty, et al.
Surgery|October 9, 2024
Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrenceSaba Kurtom, Jason B Liu, William R Doerfler, et al.
Cancer Cytopathology|August 14, 2012
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinomaN Paul Ohori, Rashi Singhal, Marina N Nikiforova, et al.
Cancer|February 4, 2021
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control studyLinwah Yip, William E Gooding, Alyaksandr Nikitski, et al.
Annals of Surgical Oncology|May 20, 2011
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancerGina M Howell, Sally E Carty, Michaele J Armstrong, et al.
Thyroid : Official Journal of the American Thyroid Association|March 28, 2023
Molecular Testing Predicts Incomplete Response to Initial Therapy in Differentiated Thyroid Carcinoma Without Lateral Neck or Distant Metastasis at Presentation: Retrospective Cohort StudyJason B Liu, Katherine A Baugh, Kimberly M Ramonell, et al.
Surgery|November 6, 2024
Entrustable Professional Activities in endocrine surgery: A national pilot studyPolina Zmijewski, M Chandler McLeod, Ramsha Akhund, et al.
Cancer Cytopathology|October 18, 2023
Molecular-derived risk of malignancy and the related positive call rate of indeterminate thyroid cytology diagnoses as quality metrics for individual cytopathologistsN Paul Ohori, Jacqueline M Cuda, Sheldon I Bastacky, et al.
Cancer Cytopathology|September 11, 2024
Parsing the thyroid cytopathology suspicious for malignancy diagnosis through molecular-derived risk of malignancy and other related parameters: Insights into nodule characteristics and practice patternsDavid Starr, Youley Tjendra, Jaylou M Velez Torres, et al.
Pageof 21